NYU Langone Health is an academic medical center located in New York City, New York, United States, affiliated with New York University.

There are 1,350 (total of all hospitals combined) beds in NYU Langone Health.

During the past decade, NYU Langone Health conducted 641 clinical trials. In the 10-year time frame, 641 clinical trials started and 169 clinical trials were completed, i.e. on average, 26.4% percent of trials that started reached the finish line to date. In the past 5 years, 427 clinical trials started and 106 clinical trials were completed. i.e. 24.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NYU Langone Health" #1 sponsor was "NYU Langone Health" with 342 trials, followed by "Abbott Medical Devices" with 20 trials sponsored, "Pfizer" with 15 trials sponsored, "Celgene" with 11 trials sponsored and "Eli Lilly and Company" with 11 trials sponsored. Other sponsors include 363 different institutions and companies that sponsored additional 236 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NYU Langone Health" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 16 trials as a collaborator, "NYU Langone Health" with 10 trials as a collaborator, "National Institute on Aging (NIA)" with 10 trials as a collaborator, "National Institutes of Health (NIH)" with 9 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 8 trials as a collaborator. Other collaborators include 302 different institutions and companies that were collaborators in the rest 218 trials.

According to Clinical.Site data, the most researched conditions in "NYU Langone Health" are "Breast Cancer" (12 trials), "Coronary Artery Disease" (12 trials), "COVID-19" (11 trials), "Heart Failure" (11 trials) and "Melanoma" (10 trials). Many other conditions were trialed in "NYU Langone Health" in a lesser frequency.

Most popular intervention types in "NYU Langone Health" are "Drug" (312 trials), "Device" (171 trials), "Other" (135 trials), "Behavioral" (85 trials) and "Biological" (56 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (83 trials), "Nivolumab" (8 trials), "Pembrolizumab" (7 trials), "Ipilimumab" (6 trials) and "Cyclophosphamide" (5 trials). Other intervention names were less common.

The vast majority of trials in "NYU Langone Health" are 714 trials for "All" genders, 37 trials for "Female" genders and 15 trials for "Male" genders.

Currently, there are 374 active trials in "NYU Langone Health". 17 are not yet recruiting, 238 are recruiting, 103 are Active, not recruiting, and 16 are Enrolling by invitation. In total, there were 285 completed trials in NYU Langone Health, 3 suspended trials, and 65 terminated clinical trials to date.

Out of the total trials that were conducted in NYU Langone Health, 61 "Phase 1" clinical trials were conducted, 174 "Phase 2" clinical trials and 103 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 66 trials, and there were also 290 trials that are defined as “Not Applicable".

NYU Langone Health has several departments that took part in Clinical trials: "Laura and Isaac Perlmutter Cancer Center at NYU Langone" - 621 trials, "NYU Hospital for Joint Diseases" - 66 trials, "NYU Comprehensive Epilepsy Center" - 25 trials, "Arena Oncology Associates, PC" - 22 trials, "Laura And Isaac Perlmutter Cancer Center" - 16 trials, "NYU Langone Nassau Gastroenterology Associates" - 15 trials, "NYU Center for Musculoskeletal Care" - 8 trials, "NYU Urology Associates" - 7 trials, "NYU Pain Management Center" - 7 trials, "NYU Sleep Disorders Center" - 5 trials, "NYU Hepatology Associates" - 4 trials, "NYU Langone Medical Center - NYU Medical Oncology Associates" - 4 trials, "NYU Langone Hospital-Long Island Oncology" - 4 trials, "NYU Langone Rheumatology Associates Long Island" - 3 trials, "Perlmutter Cancer Center at NYU Langone Hospital-Long Island" - 3 trials, "Rusk Institute of Rehabilitation Medicine" - 3 trials, "New York Cardiovascular Associates" - 3 trials, "NYU Langone Urology Associates" - 3 trials, "Aging and Dementia Research Center, Silberstein Institute, NYU School of Medicine" - 3 trials, "NYU Langone Long Island Clinical Research Associates" - 2 trials, "Hassenfeld Children's Hospital at NYU Langone" - 2 trials, "NYU Winthrop Hospital, Infusion Center" - 2 trials, "New York University School of Medicine / NYU Gastroenterology Associates" - 2 trials, "New York Otology" - 2 trials, "NYU Langone Health - Heart Rhythm Center" - 2 trials